< Back to Schedule

Parallel Session: Hepatotoxicity

Sunday, November 15
 
5:30 pm
 - 
7:00 pm

Speakers

No items found.

About the Session

Watch this live session to see some the top research in Hepatotoxicity. Content will only be aired on this date, at this time. Don't miss it!

  • Predictor and Outcomes of Steroid-Refractory Immune Checkpoint  Inhibitor Hepatitis
    Presenting Author Michael Li
  • Outcomes Following Resumption of Immune Checkpoint Inhibitor Therapy After High-Grade Immune-Mediated Hepatitis
    Presenting Author Michael Li
  • HLA Risk Alleles Associated with Drug Induced Liver Injury Due to AntiEpileptic Drugs
    Presenting Author Paola Nicoletti
  • Protection Against APAP Toxicity From RIPK1 Knockout is Mediated by increased A20 Inhibiting ASK1 and JNK Activation
    Presenting Author Andrea Lorga
  • Risk of Severe Acute Liver Injury Among Initiators of Potentially Hepatotoxic Drugs
    Presenting Author Alyssa Mezochow
  • Impact of Baseline Alanine Aminotransferase Levels on the Safety and Efficacy of Remdesivir in Moderate COVID-19 Patients
    Presenting Author Owen Tsang